Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) equity distribution for the first three quarters of 2024: 1 yuan for every 10 shares, with the equity registration on January 9.

Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) announced that the plan for equity distribution for the first three quarters of 2024 is as follows: to the public...

Zhitong FinanceJan 2 19:53

Express News | Zhejiang Wolwo Bio-Pharmaceutical: Obtained the "High-tech Enterprise Certificate".

BreakingsDec 31, 2024 17:15

Express News | Zhejiang Wolwo Bio-Pharmaceutical: Obtained registration certificates for three varieties of puncture fluid Pharmaceuticals.

BreakingsDec 23, 2024 11:45

Express News | Zhejiang Wolwo Bio-Pharmaceutical: The company's "house dust mite membrane agent" drug clinical trial application has been approved.

BreakingsDec 16, 2024 17:25

Express News | "Top-tier" fund managers frequently appear! These companies are receiving attention.

BreakingsNov 11, 2024 13:55

zhejiang wolwo bio-pharmaceutical (300357): steady growth in performance with continuous expansion of the pipeline under research.

Event: The company released the third quarter report of 2024, achieving an income of 0.73 billion yuan in the first three quarters of 24 years ago (+8.4%), net income attributable to the parent company of 0.27 billion yuan (+0.8%), and non-net income attributable to the parent company of 0.26 billion yuan (+0.3%).

Southwest SecuritiesOct 29, 2024 00:00